Financial Performance - Total operating revenue for Q1 2023 was RMB 6,477,062,887.66, an increase of 35.69% compared to RMB 4,773,517,945.43 in the same period last year[3] - Net profit attributable to shareholders for Q1 2023 was RMB 2,156,742,527.33, representing a 65.58% increase from RMB 1,302,527,153.83 in Q1 2022[3] - Basic earnings per share for Q1 2023 was RMB 0.27, up from RMB 0.17 in the same period last year, reflecting a 58.82% increase[3] - The total profit amounted to ¥2,838,034,953.16, compared to ¥1,821,456,176.17 in the previous period, reflecting a strong performance[16] - Net profit attributable to the parent company's shareholders was ¥2,156,742,527.33, up from ¥1,302,527,153.83, showcasing a robust increase[16] - The total comprehensive income attributable to the parent company's shareholders increased to ¥2,205,927,613.97 from ¥974,158,635.85, representing a significant growth[16] Assets and Liabilities - Total assets as of March 31, 2023, were RMB 664,447,965,942.89, an increase of 7.65% from RMB 617,256,282,802.40 at the end of the previous year[3] - Total liabilities increased to ¥536.68 billion from ¥492.46 billion, an increase of approximately 9.0%[13] - As of March 31, 2023, the company's net assets were CNY 124.793 billion, with total borrowings amounting to CNY 346.187 billion, representing a 25.63% increase in borrowings compared to the previous year's net assets[10] Cash Flow - The net cash flow from operating activities for Q1 2023 was RMB -4,582,031,552.90, a significant decrease compared to RMB 13,721,694,703.99 in Q1 2022[3] - Cash received from operating activities totaled ¥47,907,559,435.46, down from ¥58,198,678,471.47, indicating a decrease in cash inflow[17] - The net cash flow from investment activities was ¥33,026,890,070.77, compared to ¥4,246,862,881.19 previously, showing a significant increase[17] - Cash inflow from financing activities totaled approximately ¥29.26 billion, an increase from ¥25.55 billion in the previous period, reflecting a growth of about 6.7%[18] - The company reported a cash outflow of approximately ¥25.15 billion for debt repayment, down from ¥41.2 billion in the previous period, a decrease of about 39%[18] Shareholder Information - As of the end of the reporting period, the total number of ordinary shareholders is 244,409, with 242,921 being A-share shareholders[7] - The top 10 shareholders hold significant stakes, with Hong Kong Central Clearing (Agent) Limited owning 22.31% (1,700,147,050 shares) and Jilin Aodong Pharmaceutical Group holding 16.43% (1,252,297,867 shares)[8] - The company has no shareholders holding shares through credit securities accounts as of the end of the reporting period[9] Business Operations - The company has 25 branches and 315 securities business departments across 31 provinces, municipalities, and autonomous regions in China as of March 31, 2023[9] - The company is undergoing organizational restructuring in its retail business, renaming departments to enhance operational efficiency[9] - The company is actively cooperating with the China Securities Regulatory Commission regarding an investigation into its underwriting business practices[10] Regulatory and Market Activities - The company received regulatory approval from the China Securities Regulatory Commission to conduct index options market-making business[9] - The company plans to expand its market presence and invest in new technologies to enhance growth prospects[11] Financial Investments - The company's trading financial assets increased by 32.76% to RMB 209,488,894,233.11 from RMB 157,800,506,159.32[6] - The company's investment income for Q1 2023 was RMB 1,504,600,613.70, a recovery from a loss of RMB 571,686,079.49 in the same period last year[6] - Financial investments rose to ¥352.26 billion, up from ¥302.82 billion, marking a growth of about 16.4%[11] Other Financial Metrics - The company reported operating profit of ¥2,837,702,862.91, up from ¥1,826,341,224.81, reflecting improved operational efficiency[16] - The company reported a 41.36% increase in business and management expenses, totaling RMB 3,624,425,152.69 for Q1 2023[6] - The company experienced a 75.94% increase in derivative financial liabilities, reaching RMB 3,691,732,848.40 as of March 31, 2023[6]
广发证券(01776) - 2023 Q1 - 季度业绩